Standard InChI: InChI=1S/C52H73F3N8O11S/c1-7-18-62(31-35(2)58-47(66)40-16-14-39(15-17-40)46-60-50(74-61-46)52(53,54)55)19-8-9-20-69-21-22-70-23-24-71-25-26-72-27-28-73-33-43(65)59-45(51(4,5)6)49(68)63-32-41(64)29-42(63)48(67)56-30-37-10-12-38(13-11-37)44-36(3)57-34-75-44/h10-17,34-35,41-42,45,64H,7-9,18-33H2,1-6H3,(H,56,67)(H,58,66)(H,59,65)/t35-,41-,42+,45-/m1/s1
Standard InChI Key: KBDZFZJFGKYVBZ-KLSSUPLUSA-N
Associated Targets(Human)
Histone deacetylase 4 2328 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Histone deacetylase 5 941 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Histone deacetylase 7 1047 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Histone deacetylase 9 708 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Class 1 histone deacetylase 459 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
VHL/Histone deacetylase 4 28 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
VHL/Histone deacetylase 1 90 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
VHL/Histone deacetylase 3 77 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
VHL/Histone deacetylase 5 3 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
VHL/Histone deacetylase 7 3 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
VHL/HDAC9 2 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Vhl/Hdac4 4 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type:
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 1075.26
Molecular Weight (Monoisotopic): 1074.5072
AlogP:
#Rotatable Bonds:
Polar Surface Area:
Molecular Species:
HBA:
HBD:
#RO5 Violations:
HBA (Lipinski):
HBD (Lipinski):
#RO5 Violations (Lipinski):
CX Acidic pKa:
CX Basic pKa:
CX LogP:
CX LogD:
Aromatic Rings:
Heavy Atoms:
QED Weighted:
Np Likeness Score:
References
1.Macabuag N, Esmieu W, Breccia P, Jarvis R, Blackaby W, Lazari O, Urbonas L, Eznarriaga M, Williams R, Strijbosch A, Van de Bospoort R, Matthews K, Clissold C, Ladduwahetty T, Vater H, Heaphy P, Stafford DG, Wang HJ, Mangette JE, McAllister G, Beaumont V, Vogt TF, Wilkinson HA, Doherty EM, Dominguez C.. (2022) Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology., 65 (18.0):[PMID:36098485][10.1021/acs.jmedchem.2c01149]